Siemens Healthcare launched the ADVIA® 2120i Hematology System, the latest addition to the company's family of hematology instruments used in the clinical laboratory. The system provides the most current technology for white blood cell differential, red blood cell, reticulocyte, platelet and cerebral spinal fluid testing, benefiting all sizes and types of hematology laboratories, including routine, specialty, University, oncology and research laboratories. This new hematology system has many automation features that save laboratory personnel's time, allowing laboratories to improve productivity and reduce costs.
Some of the new time-saving features include:
The system also features:
"The demands to improve productivity and efficiencies in the hematology clinical laboratory increase everyday," said Michael Noeh, vice president, global marketing hematology and hemostasis, Siemens Healthcare Diagnostics. "We believe that by listening to our customers, we are able to invest in the right technology for their hematology laboratory and provide them with the innovation and improved automation capabilities they expect from us. We can offer customers practical automation that streamlines their workflow by eliminating the majority of manual steps - including many microscopic reviews commonly performed in hematology testing."
Many of the new system's features are customer-inspired from ADVIA 2120 Hematology System user feedback. The ADVIA family of hematology systems was launched in 1998, with over 5,000 instruments used in laboratories worldwide today.